Aerovate raises $44.9M via ATM offering; cash runway into 2026

Jade Biosciences, Inc.

Sold 2,662,721 shares under ATM program for net proceeds of $44.9M.
Total shares outstanding after transaction: 27,601,098.
Cash, equivalents, and securities plus ATM proceeds fund operations into 2026 per management.

item 8.01

Jade Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001798749-23-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.